Page 94 - Read Online
P. 94

Page 272               Yoshimura et al. Neuroimmunol Neuroinflammation 2020;7:264-76  I  http://dx.doi.org/10.20517/2347-8659.2020.22

               DECLARATIONS
               Authors’ contributions
               Searched literatures and wrote the manuscript: Yoshimura A, Ito M


               Availability of data and materials
               Not applicable.

               Financial support and sponsorship
               This work was supported by JSPS KAKENHI (S) JP17H06175, Challenging Research (P) JP18H05376,
               and AMED-CREST JP20gm1110009 to Yoshimura A, and JSPS KAKENHI 17K15667, 19H04817, and
               19K16618, AMED-PRIME 20gm6210012 to Ito M and by the Tomizawa Jun-ichi & Keiko Fund of
               Molecular Biology Society of Japan for Young Scientists, a Research Grant for Young Investigators by The
               Mitsubishi Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research,
               the Takeda Science Foundation, the Uehara Memorial Foundation, the Naito Memorial Foundation, the
               Kanae Foundation, the SENSHIN Medical Research Foundation, the Astellas Foundation for Research on
               Metabolic Disorders, an Inoue Research Award, a Life Science Research Award, and Keio Gijuku Academic
               Developmental Funds.


               Conflicts of interest
               Both authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2020.


               REFERENCES
               1.   Ojaghihaghighi S, Vahdati SS, Mikaeilpour A, Ramouz A. Comparison of neurological clinical manifestation in patients with hemorrhagic
                   and ischemic stroke. World J Emerg Med 2017;8:34-8.
               2.   Hankey GJ. Stroke. Lancet 2017;389:641-54.
               3.   Shichita T, Ago T, Kamouchi M, Kitazono T, Yoshimura A, et al. Novel therapeutic strategies targeting innate immune responses and
                   early inflammation after stroke. J Neurochem 2012;123 Suppl 2:29-38.
               4.   Shichita T, Ito M, Yoshimura A. Post-ischemic inflammation regulates neural damage and protection. Front Cell Neurosci 2014;8:319.
               5.   Jiang C, Kong W, Wang Y, Ziai W, Yang Q, et al. Changes in the cellular immune system and circulating inflammatory markers of stroke
                   patients. Oncotarget 2017;8:3553-67.
               6.   Dokalis N, Prinz M. Resolution of neuroinflammation: mechanisms and potential therapeutic option. Semin Immunopathol 2019;41:699-
                   709.
               7.   Javidi E, Magnus T. Autoimmunity after ischemic stroke and brain injury. Front Immunol 2019;10:686.
               8.   Malone K, Amu S, Moore AC, Waeber C. The immune system and stroke: from current targets to future therapy. Immunol Cell Biol
                   2019;97:5-16.
               9.   Ito M, Komai K, Mise-Omata S, Iizuka-Koga M, Noguchi Y, et al. Brain regulatory T cells suppress astrogliosis and potentiate
                   neurological recovery. Nature 2019;565:246-50.
               10.  Stubbe T, Ebner F, Richter D, Engel O, Klehmet J, et al. Regulatory T cells accumulate and proliferate in the ischemic hemisphere for up
                   to 30 days after MCAO. J Cereb Blood Flow Metab 2013;33:37-47.
               11.  Chen C, Chencheng Z, Cuiying L, Xiaokun G. Plasmacytoid dendritic cells protect against middle cerebral artery occlusion induced brain
                   injury by priming regulatory T cells. Front Cell Neurosci 2020;14:8.
               12.  Liu X, Hu R, Pei L, Si P, Wang C, et al. Regulatory T cell is critical for interleukin-33-mediated neuroprotection against stroke. Exp
                   Neurol 2020;328:113233.
   89   90   91   92   93   94   95   96   97   98   99